BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 35563712)

  • 1. Targeting Epigenetic Regulators with HDAC and BET Inhibitors to Modulate Muscle Wasting.
    Nevi L; Pöllänen N; Penna F; Caretti G
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 12th Cachexia Conference.
    Ebner N; Anker SD; von Haehling S
    J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):274-285. PubMed ID: 32049447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscle and Bone Defects in Metastatic Disease.
    Pauk M; Saito H; Hesse E; Taipaleenmäki H
    Curr Osteoporos Rep; 2022 Oct; 20(5):273-289. PubMed ID: 35994202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptococcal quorum sensing peptide CSP-7 contributes to muscle inflammation and wasting.
    De Spiegeleer A; Descamps A; Wynendaele E; Naumovski P; Crombez L; Planas M; Feliu L; Knappe D; Mouly V; Bigot A; Bielza R; Hoffmann R; Van Den Noortgate N; Elewaut D; De Spiegeleer B
    Biochim Biophys Acta Mol Basis Dis; 2024 Apr; 1870(4):167094. PubMed ID: 38428683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnosol ameliorated cancer cachexia-associated myotube atrophy by targeting P5CS and its downstream pathways.
    Fang QY; Wang YP; Zhang RQ; Fan M; Feng LX; Guo XD; Cheng CR; Zhang XW; Liu X
    Front Pharmacol; 2023; 14():1291194. PubMed ID: 38249348
    [No Abstract]   [Full Text] [Related]  

  • 6. Unlocking the wasting enigma: Highlights from the 8th Cachexia Conference.
    Ebner N; von Haehling S
    J Cachexia Sarcopenia Muscle; 2016 Mar; 7(1):90-4. PubMed ID: 27128291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles in cancer cachexia: deciphering pathogenic roles and exploring therapeutic horizons.
    Wang Y; Ding S
    J Transl Med; 2024 May; 22(1):506. PubMed ID: 38802952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes in the pathogenesis and treatment of cancer-related cachexia.
    Ru Q; Chen L; Xu G; Wu Y
    J Transl Med; 2024 Apr; 22(1):408. PubMed ID: 38689293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of extracellular vesicles in skeletal muscle wasting.
    Zhang X; Zhao Y; Yan W
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2462-2472. PubMed ID: 37867162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management.
    Argilés JM; López-Soriano FJ; Stemmler B; Busquets S
    Nat Rev Clin Oncol; 2023 Apr; 20(4):250-264. PubMed ID: 36806788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-mediated regulatory mechanisms in skeletal muscle: a narrative review.
    Wang Z; Yang J; Sun X; Sun X; Yang G; Shi X
    J Zhejiang Univ Sci B; 2023 Jan; 24(1):1-14. PubMed ID: 36632747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics analysis of C2C12 myotubes treated with atrophy inducing cancer cell-derived factors.
    Marzan AL; Chitti SV; Gummadi S; Kang T; Ang CS; Mathivanan S
    Proteomics; 2024 Jun; 24(11):e2300020. PubMed ID: 37882347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Derived Pancreatic Cancer Cells Induce C2C12 Myotube Atrophy by Releasing Hsp70 and Hsp90.
    Wu HY; Trevino JG; Fang BL; Riner AN; Vudatha V; Zhang GH; Li YP
    Cells; 2022 Sep; 11(17):. PubMed ID: 36078164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal muscle wasting after a severe burn is a consequence of cachexia and sarcopenia.
    Song J; Clark A; Wade CE; Wolf SE
    JPEN J Parenter Enteral Nutr; 2021 Nov; 45(8):1627-1633. PubMed ID: 34296448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms and treatment targets of muscle wasting and cachexia in heart failure: an overview.
    Ebner N; Elsner S; Springer J; von Haehling S
    Curr Opin Support Palliat Care; 2014 Mar; 8(1):15-24. PubMed ID: 24452279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiactisome: A New Nanovesicle Drug Containing Heat Shock Protein 60 for Treating Muscle Wasting and Cachexia.
    Di Felice V; Barone R; Trovato E; D'Amico D; Macaluso F; Campanella C; Marino Gammazza A; Muccilli V; Cunsolo V; Cancemi P; Multhoff G; Coletti D; Adamo S; Farina F; Cappello F
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563712
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.